论文部分内容阅读
目的:探究小肝癌患者通过手术切除与经皮射频消融治疗后取得的临床成效。方法:选取我院2015年1月-2016年6月入院的小肝癌患者80例,随机分组法分为观察组和对照组,每一组40人。对照组患者治疗方法为手术切除治疗,观察组方法为经皮射频消融治疗。针对临床治疗有效率、不良反应发生情况,对两组进行对比分析。结果:在临床治疗效果方面,观察组治疗总有效率(95%)与对照组(90%)相比差异不明显(P>0.05);针对不良反应发生情况,观察组发生率(7.5%)显著低于对照组发生率(25%),两组之间存在明显差异(P<0.05)。结论:小肝癌患者通过手术切除与经皮射频消融治疗后取得的临床成效均较显著,但经皮射频消融治疗后,不良反应发生率较手术切除治疗低,应在临床大力推广应用。
Objective: To investigate the clinical outcomes of small hepatocellular carcinoma patients after surgical resection and percutaneous radiofrequency ablation. Methods: 80 small hepatocellular carcinoma patients admitted to our hospital from January 2015 to June 2016 were randomly divided into observation group and control group, with 40 in each group. Patients in the control group were treated by surgical resection and in the observation group by percutaneous radiofrequency ablation. For clinical treatment efficiency, adverse reactions, the two groups were compared. Results: The total effective rate (95%) in the observation group was not significantly different from that in the control group (90%) (P> 0.05), and the incidence of adverse reactions (7.5%) in the observation group Significantly lower than the control group (25%), there was a significant difference between the two groups (P <0.05). Conclusion: The clinical outcomes of patients with small hepatocellular carcinoma after surgical resection and percutaneous radiofrequency ablation were all significant. However, the incidence of adverse reactions after percutaneous radiofrequency ablation was lower than that of surgical resection and should be promoted in clinical practice.